Recent findings from our POSITIVE trial now out in the Journal of Clinical Oncology (JCO)

Breastfeeding after hormone-sensitive early breast cancer is feasible and does not increase short-term recurrence risk.
A meaningful step forward for young breast cancer survivors navigating family planning.

Breastfeeding After Hormone Receptor–Positive Breast Cancer: Results From the POSITIVE Trial